Protocol of the 64-Slice MDCT Scan
Coronary MDCT-angiography was performed using a 64-slice MDCT scanner (Light Speed VCT, GE Healthcare, WI, USA). Prior to the MDCT angiography, a test injection was given to determine the delay time of the main scanning. A monitoring scan was acquired at the center of the ascending aorta. To measure the time of maximum enhancement, an enhancement curve was created during a test injection. In the main scanning, contrast material (Iopamiron 370; Nihon Schering, Japan) and a saline chaser of 20 ml was injected at a rate of 3.2-4.0 ml/s and the main scanning was started after the delay time (the time to peak enhancement for the test injection plus 3 s). Images including the whole heart were acquired during a breath hold for 7-9 s. The detector collimation was 64×0.625 mm, the gantry rotation speed was 350 ms/rotation, the tube voltage was 120 kV at a current of 350-700 mA, and the table feed was 8 mm/rotation.
Image Reconstruction and an Analysis of the Coronary Artery
The MDCT images were sent to a workstation (Advanced Workstation 4.2, GE Healthcare, WI, USA) where they were reconstructed and analyzed by 2 independent readers. Serial multi-planar reconstructions were created and a cylindricalshaped, 3-dimensional region of interest (ROI) was defined in the target lesion along the visually estimated centerline of the target vessel in the MPR image. The ROI diameter was 
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defined based on the outer vessel contour identified by visual estimation. As the vessel diameter varied along the longitudinal axis of the MPR image, the target lesion was divided into 1-2 ROIs. Using Color Code Plaque™ (GE Healthcare), as previously reported, 17 the volume of each component of coronary plaque within the ROI was measured automatically, based on the stratified CT density. As previously reported, 18 each plaque component and lumen (filled with contrast medium) were defined as follows: (1) low-density (~50 Hounsfield units [HU]); (2) moderate-density (50-150 HU); (3) lumen (150-500 HU); (4) high-density (500 HU~). The total plaque volume (TPV) [sum of volume of LDP, moderate-density plaque (MDP) and high-density plaque (HDP)] and the fraction of each plaque component, defined as the volume of each component divided by the TPV, were also estimated. Analyzed segments were defined as the ostium of the left anterior descending artery, left circumflex artery, and right coronary artery with a 10 mm length. We calculated the following indexes: (1) 
Statistical Analysis
We used SPSS (SPSS Inc, Chicago, IL, USA) to perform statistical analyses. Continuous variables were expressed as mean ± standard deviation unless otherwise specified. Comparisons of continuous variables were performed using the Student's t-test and categorical variables were analyzed by a chi-squared analysis or Fisher's exact probability test, as appropriate. A simple regression analysis and multivariate linear regression analysis were used to test the relationship between incidence of MetS and clinical, laboratory, and MDCT parameters. Factors with a P<0.10 on the univariate analysis were entered into the multiple regression analysis. We arbitrarily defined the cut-off point for the lipid-rich plaque as 27.6% for %LDPV and 61.1% for %MDPV, which were the 75 th percentile of %LDPV and 25 th percentile of %MDPV.
Differences were considered significant at the 5% level.
Results
Ninety-four patients with 282 target segments were evaluated in the present study. Clinical variables of the total population are shown in Table 1 . The prevalence of MetS was 48% (45 patients). Waist circumference, serum triglyceride levels, high-density lipoprotein cholesterol levels and incidence of 
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diabetes mellitus were significantly greater in the MetS group compared to the non-MetS group. In addition, body mass index, immunoreactive insulin, and homeostasis model assessment ratio (HOMA-R) were also significantly increased in the MetS group. Regarding medical drugs, only β-blockers had a significant difference between the 2 groups. All other drugs provided no significant difference. 
Volumetric Plaque Measurements Using MDCT

Association of MetS Components With Tissue Characteristics of Coronary Plaque
The results of simple regression analysis demonstrated that the prevalence of MetS (β=0.33, P=0.0014), serum triglyceride levels (β=0.27, P=0.0092) and waist circumference (β= 0.25, P=0.0017) were significantly associated with %LDPV ARAI K et al.
( Table 3) . The results of multiple regression analysis demonstrated that the prevalence of MetS (β=0.48, P=0.0001) was only significantly associated with %LDPV after adjustment for confounding and pre-defined variables ( Table 4) .
We next classified, regardless of the presence of MetS, all 94 patients based on the number of each MetS component: (1) waist circumference ≥90 cm in females and ≥85 cm in males; (2) systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg; (3) serum triglyceride levels ≥150 mg/dl and/or serum high-density lipoprotein cholesterol levels <40 mg/dl; and (4) fasting glucose levels ≥110 mg/dl).
The results of an ANOVA demonstrated that patients with 4 risks had a significantly increased %LDPV compared to those with 0-2 risks (Figure 2) .
Multivariate logistic regression analysis for lipid-rich plaque after adjusting for confounding variables indicated that MetS was significantly associated with lipid-rich plaque formation (odds ratio: 5.99, 95% confidence interval: 1.94-18.6, P=0.002).
Discussion
We found that patients with MetS were strongly related to having a lipid-rich composition in their coronary plaque, even after multivariate regression analysis was conducted using other coronary risk factors.
Reports have shown that large lipid cores are histological markers for vulnerable atherosclerotic plaque that is highly related to a risk of its rupture. 19, 20 Although it has been gradually clarified as to why patients with MetS have high rates of cardiovascular events such as ACS, our current findings further confirm the presence of vulnerable plaque in patients with MetS, using a novel non-invasive diagnostic modality, MDCT.
Advanced vascular damage is often associated with the presence of MetS in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. 5 Tartan et al showed that patients with MetS more frequently experienced a no-reflow phenomenon after primary percutaneous coronary intervention for ST-elevation myocardial infarction compared to non-MetS patients. 21 Components of MetS include impaired glucose tolerance, diabetes, hypertension, dyslipidemia, and obesity, which are all major cardiovascular risk factors. 22 Furthermore, we previously reported that MetS or high insulin levels were significantly associated with coronary lipid-rich plaque, as detected by integrated backscatter IVUS. 9,23 Catheter-based modalities including IVUS provides precise tissue information, however, their invasive nature often limits clinical use. Therefore, a simple non-invasive method to determine the presence of a coronary lesion, such as MDCT, is preferred, especially in patients with a high risk. However, until recently, there have been only few data on quantitative and volumetric analysis of coronary plaque components by MDCT. In the present study, we have demonstrated unique characteristics of plaque composition in patients with MetS. Furthermore, our findings might contribute to non-invasive risk stratification in such populations. From this point, our findings are of clinically relevance.
Patients who have positively remodeled coronary segments and have had a LDP detected by MDCT are associated with an increased risk of future ACS. 15, 24 Recently, we have reported that coronary plaque with a large LDP volume is related to post-procedural myocardial infarction in elective PCI cases. 18 A report suggests that the presence of a large LDP volume increases the incidence of a no-reflow phenomenon in patients undergoing PCI. 25 Therefore, much careful attention should be paid to the treatment of coronary plaque with a large LDP volume. In such cases, intensive pre-procedural pharmacological intervention to stabilize the coronary plaque might be effective to prevent procedural complications, particularly in patients with MetS. Statins have been shown to attenuate the progression of the lipid pool and positive remodeling, as demonstrated by conventional and integrated backscatter IVUS. [26] [27] [28] There are only few data available regarding plaque profiles determined by MDCT, and the findings by MDCT might be different from those assessed by IVUS. 29, 30 Future clinical studies examining coronary plaques using both MDCT and IVUS will provide more useful information to predict ACS in patients with MetS.
Study Limitations
Several limitations need to be considered. First, our study is a single-centre design with a small number of patients. Larger multi-centre studies are warranted to corroborate our findings. Second, patients with an eGFR <30 ml · min -1 · 1.73 m -2 were excluded because CT angiographies need contrast media. Therefore, we could not evaluate MDCT images in patients with severe renal dysfunction. Third, we analyzed the ostium of LAD, LCx and RCA with a 10 mm length because proximal portions of coronary arteries have been identified as the most frequent sites of plaque rupture resulting in ACS. 31, 32 Other coronary segments were not evaluated. Fourth, the cutoff points for the lipid-rich plaque were 27.6% for %LDPV and 61.1% for %MDPV, which were the 75 th percentile of %LDPV and 25 th percentile of %MDPV. The arbitrary definition was a limitation of the study. Fifth, acquisitions of MDCT images involve significantly greater exposure to radiation and contrast medium complications. The mean of the radiation dose of one scan was 1,351 DLP. Finally, the concept of MetS has been internationally debated and the defining criteria of obsesity might need to be looked at more carefully, 33 although we used a waist circumference of 90 cm as the cut-off point of central obesity for females according to the JSIM criteria. Further investigation is needed.
Conclusions
The present study using MDCT, a novel non-invasive modality, clearly documents that patients with MetS, who are at a high risk of suffering cardiovascular events, are indeed associated with increased LDP, which is thought to be related to adverse coronary events.
